Related Experiment Video
Updated: Jun 8, 2026

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders
Lothar Gremer1, Torsten Merbitz-Zahradnik, Radovan Dvorsky
1Institute of Biochemistry and Molecular Biology II, Heinrich-Heine University, Düsseldorf, Germany.
Abstract:
The KRAS gene is the most common locus for somatic gain-of-function mutations in human cancer. Germline KRAS mutations were shown recently to be associated with developmental disorders, including Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS). The molecular basis of this broad phenotypic variability has in part remained elusive so far. Here, we comprehensively analyzed the biochemical and structural features of ten germline KRAS mutations using physical and cellular biochemistry. According to their distinct biochemical and structural alterations, the mutants can be grouped into five distinct classes, four of which markedly differ from RAS oncoproteins. Investigated functional alterations comprise the enhancement of intrinsic and guanine nucleotide exchange factor (GEF) catalyzed nucleotide exchange, which is alternatively accompanied by an impaired GTPase-activating protein (GAP) stimulated GTP hydrolysis, an overall loss of functional properties, and a deficiency in effector interaction. In conclusion, our data underscore the important role of RAS in the pathogenesis of the group of related disorders including NS, CFCS, and CS, and provide clues to the high phenotypic variability of patients with germline KRAS mutations.
Insights
Germline KRAS mutations cause developmental disorders like Noonan syndrome. This study classifies ten KRAS mutations by their biochemical and structural changes, explaining disease variability.
Area of Science:
- Molecular biology
- Genetics
- Biochemistry
Background:
- The KRAS gene is frequently mutated in cancer.
- Germline KRAS mutations are linked to developmental disorders such as Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS).
- The molecular mechanisms driving the diverse phenotypes in these syndromes remain incompletely understood.
Purpose of the Study:
- To comprehensively analyze the biochemical and structural characteristics of ten distinct germline KRAS mutations.
- To elucidate the molecular basis for the phenotypic variability observed in patients with germline KRAS mutations.
Main Methods:
- Utilized physical and cellular biochemistry techniques.
- Performed comprehensive analysis of ten germline KRAS mutations.
- Grouped mutants based on distinct biochemical and structural alterations.
Main Results:
- Identified five distinct classes of germline KRAS mutants based on biochemical and structural properties.
- Four of these classes exhibited significant differences compared to RAS oncoproteins.
- Observed functional alterations including enhanced nucleotide exchange (intrinsic and GEF-catalyzed), impaired GTP hydrolysis (GAP-stimulated), loss of function, and deficient effector interaction.
Conclusions:
- Germline KRAS mutations play a significant role in the pathogenesis of NS, CFCS, and CS.
- The diverse biochemical and structural alterations of KRAS mutants provide insights into the phenotypic variability in related developmental disorders.
- This research deepens the understanding of RAS pathway dysregulation in human development.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Abnormal Proliferation
Inborn Errors of Metabolism
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

